Drug Database
Back to search

Italy· 035952023

PANTOXON

A ceftriaxone product containing ceftriaxone, registered in Italy by AESCULAPIUS FARMACEUTICI S.R.L., on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC J01DD04

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedPANTOXONATCJ01DD04REGISTER NO.035952023PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ceftriaxoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ceftriaxone is registered in 19 of 19 countries.

Countries holding a registration under ATC J01DD04 (ceftriaxone), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 11 of them publish a price we can compare per daily dose
Search ceftriaxone products by name

Ceftriaxone · ATC J01DD04

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ceftriaxone costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $3.23 in Finland to $33.98 in Switzerland — a ×11 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ceftriaxone · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$33.98
  • FR France$13.68
  • ES Spain$5.69
  • FI Finland$3.23
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Ceftriaxone
Manufacturer
AESCULAPIUS FARMACEUTICI S.R.L.
Country
Italy (IT)
ATC code
J01DD04
ATC class
Ceftriaxone
Defined daily dose
2 g, P
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    035952023
    "1 G/3,5 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE" FLACONE POLVERE + 1 FIALA SOLVENTE 3,5 ML
    EUR 4.96

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

233 interactions on record for ceftriaxone.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ceftriaxone against other medicinesHow interaction checks work

Ceftriaxone · interactions on record

233 records

  • 7 severe
  • 20 moderate
  • 3 minor
  • 203 info

Most severe, free to view

  • Calcium gluconateA12AA03severe
  • Calcium chlorideA12AA07severe
  • Calcium glucoheptonateA12AA10severe
  • Calcium chlorideB05XA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ceftriaxone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ceftriaxone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ceftriaxon Aptapharma, Ceftriaxon Ashcure
  • Belgium · Ceftriaxon Hameln, Ceftriaxone Fresenius Kabi
  • Bulgaria · Медаксон, Цефамед
  • Cyprus · Ceftriaxone Sapiens, Ceftrix
  • Czechia · Ceftriaxon Aptapharma, Ceftriaxon Kabi
  • Germany · Ceftriaxon Cnp, Ceftriaxon Dali Pharma
  • Denmark · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
  • Estonia · ceftriaxone Kabi, Ceftriaxone Mip
  • Spain · Ceftriaxona Fresenius Kabi, Ceftriaxona Ldp Torlan
  • Finland · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
  • France · Ceftriaxone Almus, Ceftriaxone Arrow
  • United Kingdom (Northern Ireland) · Ceftriaxone, Ceftriaxone Aft Pharma Uk
  • Greece · Bresec, Bresec(Iv)
  • Croatia · Ceftriakson Aptapharma, Ceftriakson Pontus
  • Hungary · Ceftriaxon Aptapharma, Ceftriaxon Kabi
  • Ireland · Ceftriaxone Hameln, Ceftriaxone Jed Pharma
  • Iceland · Ceftriaxon Fresenius Kabi, Ceftriaxon Navamedic
  • Lithuania · Ceftriaxone Ashcure, Ceftriaxone Kabi
  • Luxembourg · Ceftriaxone Fresenius Kabi, Rocephine
  • Latvia · Ceftriaxon Mip, Ceftriaxone Ashcure
  • Malta · Ceftriaxone Ashcure, Ceftriaxone Dali Pharma
  • Netherlands · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
  • Norway · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
  • Poland · Biotrakson, Ceftriaxon Aptapharma
  • Portugal · Betasporina, Betasporina Im
  • Romania · Cefort, Ceftriaxonă Aptapharma
  • Sweden · Ceftriaxon Fresenius Kabi, Ceftriaxon Hameln
  • Slovenia · Ceftriakson Aptapharma, Ceftriakson Pontus
  • Slovakia · Ceftriaxón Aptapharma, Ceftriaxon Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0bf6e3b-4b98-4263-9cd6-2d27cef404db
GET /v1/drugs/e0bf6e3b-4b98-4263-9cd6-2d27cef404db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"1 G/3,5 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE\" FLACONE POLVERE + 1 FIALA SOLVENTE 3,5 ML",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Ceftriaxone",
  "reference_pack": "1 UNITA' 1000 MG - USO PARENTERALE",
  "public_price_eur": 4.96,
  "ssn_reference_price_eur": 4.96
}
API referenceMCP serverPlans

See everything about ceftriaxone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console